Delivery Order SPE2DB20D1109-SPE2DB25FP37T
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,124.90 on September 15, 2025, for the supply of Valtoco 15 mg nasal sprays, with a completion date of September 16, 2025. The contract is priced on a firm fixed price basis with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Valtoco 15 mg nasal spray, a medication used for acute seizure management. This firm fixed-price delivery order, valued at $3,385.62, represents a non-competitive set-aside contract and is scheduled for completion by July 24, 2025. The award was issued from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 10 mg nasal spray, a seizure rescue medication. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.67 and is scheduled for completion by August 4, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Valtoco 10 mg nasal spray in a 5-pack unit configuration. This competitively awarded, non-set-aside contract carries a ceiling value of $3,388.86 under firm fixed pricing terms, with ultimate completion scheduled for June 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,743.34 for Valtoco 10 mg nasal sprays, a medication used in emergency seizure management. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $3,386.58 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of September 4, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Valtoco 15 mg nasal sprays, valued at $3,771.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to be completed by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,126.10 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays. This firm fixed price, competitively awarded delivery order was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP37TDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 11, 2025, for the supply of Valtoco 10 mg nasal sprays. The contract is valued at $1,616.58 and carries a completion date of July 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that enables pharmaceutical procurement to support military healthcare systems globally. Valtoco is an emergency rescue medication approved for use in seizure management, reflecting the DLA Medical Supply Chain's ongoing need to stock critical pharmaceutical products across military and federal healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill diverse medical supply requirements through open competition, with consistent delivery of brand-name and generic medications, specialty drugs, and related medical supplies to defense and civilian federal agencies. This delivery order represents a routine procurement transaction under the company's broader pharmaceutical prime vendor arrangement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/11/25 |